Login to Your Account

Panel Fact-Finders Question Waksal, Others On ImClone

By Kim Coghill

Friday, June 14, 2002
WASHINGTON - Members of a House subcommittee on Thursday were pointing their fingers in all sorts of directions, looking for someone to accept blame for the debacle surrounding ImClone Systems Inc.'s investigational cancer drug, Erbitux. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription